약물용출 스텐트를 이용한 Full Metal Jacket (≥60 mm) 시술의 단기 및 장기 성적
Background and Objectives: Drug-eluting stents (DES) are effective for the maintenance of patency in patients with various complex coronary artery diseases. We investigated the efficacy of full metal jackets (FMJs,≥60 mm) using overlapping DES for very long coronary lesions. Subjects and Methods: Th...
Saved in:
Published in | Korean circulation journal pp. 87 - 94 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | Korean |
Published |
대한심장학회
01.02.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background and Objectives: Drug-eluting stents (DES) are effective for the maintenance of patency in patients
with various complex coronary artery diseases. We investigated the efficacy of full metal jackets (FMJs,≥60 mm)
using overlapping DES for very long coronary lesions. Subjects and Methods: The medical records and angiographic
data of ninety-nine patients, and 100 FMJs that were implanted at Chonbuk National University Hospital
since March 2003, were analyzed. Results: The mean age was 63±10 years and median follow-up period
was 17.0 months. The mean lesion length was 57.7±10.8 mm, the mean number of implanted DES for FMJ was
2.2±0.5, and the mean length of the FMJ was 68.5±11.4 mm. Thirty percent of the lesions were the culprits of
acute myocardial infarction and 22% were chronic total occlusive lesions. The procedural success rate was 98%.
Triple antiplatelet agents were prescribed for 37.4% of the patients and the mean duration of clopidogrel use was
11.9±5.7 months. Overall major adverse cardiac events developed in 10% of patients. One patient died of probable
stent thrombosis by the Academic Research Consortium definition. Follow-up coronary angiography was performed
in 69% of cases. Binary restenosis was documented in 9 lesions (13.0%) and five FMJs (7.2%) were
revascularized. Stent fractures were detected in four FMJs (5.8%). Conclusion: Although FMJs using DES may be
regarded as a relatively safe and effective therapeutic approach for diffuse long coronary lesions, longer-term
follow-up data with a larger population is needed to establish safety including special consideration for strategy
of antiplatelet therapy. KCI Citation Count: 2 |
---|---|
Bibliography: | G704-000708.2008.38.2.003 |
ISSN: | 1738-5520 1738-5555 |